Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays

@article{Wadman2020NovavaxLP,
  title={Novavax launches pivotal U.S. trial of dark horse COVID-19 vaccine after manufacturing delays},
  author={Meredith Wadman},
  journal={Science},
  year={2020}
}
  • M. Wadman
  • Published 28 December 2020
  • Business
  • Science
1 Citations

Coagulation System Activation for Targeting of COVID-19: Insights into Anticoagulants, Vaccine-Loaded Nanoparticles, and Hypercoagulability in COVID-19 Vaccines

TLDR
Light is shed on blood coagulation and its impact on the complication associated with COVID-19 and the sources of natural anticoagulants, the role of nanoparticle formulation in this outbreak, and the prevalence of thrombosis withThrombocytopenia syndrome after CO VID-19 vaccines are reviewed.